eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Head & Neck Surgery

Conservation Laryngeal Surgery, Vertical Partial Laryngectomy

Author: Jon Robitschek, MD, Resident Physician, Department of Otolaryngology, Tripler Army Medical Center
Coauthor(s): Jessica J Peck, MD, Staff Physician, Department of Otolaryngology-Head and Neck Surgery, Tripler Army Medical Center; Christopher Klem, MD, Consulting Staff, Department of Otolaryngology-Head and Neck Surgery, Tripler Army Medical Center; Christopher H Rassekh, MD, Director, Associate Professor, Department of Otolaryngology-Head and Neck Surgery, West Virginia University
Contributor Information and Disclosures

Updated: Jan 14, 2009

Introduction

Organ preservation therapy of the larynx is offered as a functional alternative to total laryngectomy. The intended goals of preservation therapy are to circumvent permanent tracheostomy, maintain laryngeal speech, and preserve swallow function. Subtypes of operations classified as organ preservation surgery of the larynx include the following: vertical partial laryngectomy (VPL), hemilaryngectomy, endoscopic cordectomy (including procedures that use lasers), and laryngofissure with cordectomy. This article focuses on the use of VPL in the treatment of early glottic cancers.

VPL is specifically designed to treat early T1 and T2 and select T3 laryngeal cancers. Despite initial local control and cure rates comparable with those of traditional radiotherapy (RT), VPL is largely reserved for patients with recurrent or persistent T1 and T2 disease for whom such therapy has failed. The intent of this article is to elucidate the clinical indications, contraindications, and technical points of interest that should be considered in connection with the use of VPL in early glottic cancer treatment.

History of the Procedure

Open transcervical vertical laryngectomy was initially proposed by Solis-Colen in 1869 to address early T1 and T2 and select T3 glottic cancer. With the advent of primary radiotherapy in the mid 20th century, open procedures were replaced as the definitive treatment for T1 and T2 disease. This was followed by the introduction of transoral laser excision (TLE), which has been popularized over the last 10 years and is considered a viable alternative to primary RT.

Classic hemilaryngectomy, in which the surgeon removes most of the thyroid cartilage on the side of a vocal cord cancer, produces variable speech and swallowing results. This problem led to the development of multiple reconstructive techniques. Among the various techniques used, the following have received particular attention: (1) false vocal cord pulldown, (2) cartilage preservation with perichondrial/sternohyoid muscle flap reconstruction, and (3) epiglottic reconstruction for defects involving the anterior commissure. More sophisticated reconstructive methods have also been described, but no matter the method, the ultimate goal is maintaining normal laryngeal function. Selection of reconstructive technique partly depends on surgeon preference but is also dictated by the extent of resection required.

Problem

VPL is primarily an operation for early glottic carcinoma.

Frequency

Early carcinoma of the glottis is more common than early carcinoma of other head and neck sites because patients present with hoarseness relatively early in the course of the disease. Because radiotherapy is a well-established treatment for early glottic cancers with good oncologic and functional results, VPL is most often reserved as salvage surgery with the aim of removing the tumor with a cuff of healthy tissue.

Etiology

The etiology of glottic carcinoma correlates strongly with tobacco abuse, and most patients with the disease are smokers. Other etiologic factors include genetic predisposition and laryngeal papillomata. The roles of other carcinogens, such as viruses, chemicals, and inflammatory mediators, are being investigated. Some authors believe that gastroesophageal reflux disease may be a contributing factor.

Pathophysiology

Carcinoma of the larynx usually begins with dysplastic changes in the larynx, which then progress to carcinoma in situ, followed by microinvasion.

Presentation

Patients with glottic carcinoma typically present with intermittent hoarseness of up to a few months' duration. A change from intermittent to constant hoarseness indicates vocal cord paralysis. In many cases, no other clinical findings are found in early glottic carcinoma other than hoarseness and indirect laryngoscopic findings of a laryngeal lesion. Early glottic cancer can manifest as leukoplakia (most common; found during examination) or as ulceration, polypoid changes, papilloma, or erythema. Consider all of these findings suggestive, particularly if found in patients who smoke.

Indications

Vertical partial laryngectomy (VPL) is indicated as both an initial therapy and as salvage therapy for early glottic cancer (T1 and T2 stages) that has been refractive to primary radiotherapy or transoral laser excision. In select cases, T3 lesions may also be addressed with this family of operations. However, it may not be appropriate in cases of recurrent glottic carcinomas, as they are often understaged and present with multiple foci of tumor throughout the larynx. 

For T1 lesions that do not involve the anterior commissure, laser cordectomy can be performed. The false vocal cord reconstruction is then feasible using imbrication laryngoplasty. This operation facilitates false vocal cord reconstruction while maintaining the bulk of the neocord by transferring vascularized innervated false cord to oppose the contralateral true vocal cord. T2 lesions classified as such by impaired mobility are also appropriately addressed in this manner.

For T2 lesions that involve the supraglottis, the false vocal cord usually cannot be pulled down. If a VPL is selected, a different reconstruction technique, such as the perichondrial/sternohyoid muscle flap procedure or a muscle/free mucosal flap procedure, should be considered.

Relevant Anatomy

See Intraoperative details in the Treatment section.

Contraindications

Cancer that involves the anterior commissure, or is close to the Broyle ligament, makes tumor invasion of the thyroid cartilage more accessible. This risk has prompted some authors to question employing vertical partial laryngectomy (VPL) for such lesions in favor of a different organ preservation technique such as supracricoid partial laryngectomy (SCPL) with cricohyoidoepiglottopexy (CHEP) or cricohyoidopexy (CHP). Although voice results following SCPL are predictably worse than after VPL, some studies have shown the local control rates following SCPL are perhaps better for selected T2 and T3 lesions of the glottis. Each case should be individualized for the patient's particular tumor and preoperative function.

Some absolute contraindications to VPL exist. These include large T3 or any T4 lesions, arytenoid fixation, thyroid cartilage invasion, interarytenoid invasion, cricoarytenoid joint invasion, subglottic extension involving the cricoid cartilage, lesions that extend outside the larynx, and pre-epiglottic space invasion.

Because of the relative lack of lymphatics in the glottic division of the larynx, glottic cancers tend to metastasize only in advanced stages. A finding of nodal disease therefore indicates more advanced disease and is a relative contraindication to VPL.

More on Conservation Laryngeal Surgery, Vertical Partial Laryngectomy

Overview: Conservation Laryngeal Surgery, Vertical Partial Laryngectomy
Workup: Conservation Laryngeal Surgery, Vertical Partial Laryngectomy
Treatment: Conservation Laryngeal Surgery, Vertical Partial Laryngectomy
Follow-up: Conservation Laryngeal Surgery, Vertical Partial Laryngectomy
Multimedia: Conservation Laryngeal Surgery, Vertical Partial Laryngectomy
References

References

  1. Zbaren P, Christe A, Caversaccio MD, et al. Pretherapeutic staging of recurrent laryngeal carcinoma: clinical findings and imaging studies compared with histopathology. Otolaryngol Head Neck Surg. Sep 2007;137(3):487-91. [Medline].

  2. Yiotakis J, Stavroulaki P, Nikolopoulos T, et al. Partial laryngectomy after irradiation failure. Otolaryngol Head Neck Surg. Feb 2003;128(2):200-9. [Medline].

  3. Brumund KT, Gutierrez-Fonseca R, Garcia D, et al. Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol. Apr 2005;114(4):314-22. [Medline].

  4. Bailey BJ. Head and Neck Surgery-Otolaryngology Atlas. Baltimore, Md:. Lippincott Williams & Wilkins;1996.

  5. Bailey BJ, Calcaterra TC. Vertical, subtotal laryngectomy and laryngoplasty. Review of experience. Arch Otolaryngol. Mar 1971;93(3):232-7. [Medline].

  6. Brasnu D, Laccourreye O, Weinstein G, et al. False vocal cord reconstruction of the glottis following vertical partial laryngectomy: a preliminary analysis. Laryngoscope. Jun 1992;102(6):717-9. [Medline].

  7. Davis RK, Hadley K, Smith ME. Endoscopic vertical partial laryngectomy. Laryngoscope. Feb 2004;114(2):236-40. [Medline].

  8. Kadish SP. Can I treat this small larynx lesion with radiation alone? Update on the radiation management of early (T1 and T2) glottic cancer. Otolaryngol Clin North Am. Feb 2005;38(1):1-9, vii. [Medline].

  9. Kambic V, Radsel Z, Smid L. Laryngeal reconstruction with epiglottis after vertical hemilaryngectomy. J Laryngol Otol. May 1976;90(5):467-73. [Medline].

  10. Laccourreye O, Weinstein G, Brasnu D, et al. Vertical partial laryngectomy: a critical analysis of local recurrence. Ann Otol Rhinol Laryngol. Jan 1991;100(1):68-71. [Medline].

  11. Pleet L, Ward PH, DeJager HJ, et al. Partial laryngectomy with imbrication reconstruction. Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol. Sep-Oct 1977;84(5):ORL882-9. [Medline].

  12. Vachin F, Hans S, Atlan D, et al. [Long term results of exclusive chemotherapy for glottic squamous cell carcinoma complete clinical responders after induction chemotherapy]. Ann Otolaryngol Chir Cervicofac. Jun 2004;121(3):140-7. [Medline].

  13. Yeager LB, Grillone GA. Organ preservation surgery for intermediate size (T2 and T3) laryngeal cancer. Otolaryngol Clin North Am. Feb 2005;38(1):11-20, vii. [Medline].

Further Reading

Keywords

laryngeal surgery, conservation laryngeal surgery, glottic carcinoma, organ preservation, neck cancer, organ preservation for glottic carcinoma, vertical partial laryngectomy, VPL, laryngofissure and cordectomy, partial laryngectomy with imbrication laryngoplasty, frontolateral partial laryngectomy, muscle flap laryngoplasty, epiglottic laryngoplasty, organ preservation surgery of the larynx, endoscopic cordectomy

Contributor Information and Disclosures

Author

Jon Robitschek, MD, Resident Physician, Department of Otolaryngology, Tripler Army Medical Center
Jon Robitschek, MD is a member of the following medical societies: Alpha Omega Alpha
Disclosure: Nothing to disclose.

Coauthor(s)

Jessica J Peck, MD, Staff Physician, Department of Otolaryngology-Head and Neck Surgery, Tripler Army Medical Center
Disclosure: Nothing to disclose.

Christopher Klem, MD, Consulting Staff, Department of Otolaryngology-Head and Neck Surgery, Tripler Army Medical Center
Christopher Klem, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, American Medical Association, and American Society for Reconstructive Microsurgery
Disclosure: Nothing to disclose.

Christopher H Rassekh, MD, Director, Associate Professor, Department of Otolaryngology-Head and Neck Surgery, West Virginia University
Christopher H Rassekh, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Cancer Society, American Head and Neck Society, American Medical Association, American Rhinologic Society, American Society for Head and Neck Surgery, and West Virginia State Medical Association
Disclosure: Nothing to disclose.

Medical Editor

David J Terris, MD, FACS, Porubsky Professor and Chairman, Department of Otolaryngology, Medical College of Georgia
David J Terris, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Association for the Advancement of Science, American Bronchoesophagological Association, American College of Surgeons, American Head and Neck Society, Federation of American Societies for Experimental Biology, International Association of Endocrine Surgeons, Phi Beta Kappa, Radiation Research Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Karen Hall Calhoun, MD, Professor, Department of Otolaryngology-Head and Neck Surgery, The Ohio State University
Karen Hall Calhoun, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, American Medical Association, American Rhinologic Society, Association for Research in Otolaryngology, Society of University Otolaryngologists-Head and Neck Surgeons, Southern Medical Association, Texas Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.